Chesley Taft & Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
3,106
+53
+2% +$16.1K 0.05% 194
2026
Q1
$652K Sell
3,053
-208
-6% -$46.5K 0.03% 257
2025
Q4
$558K Sell
3,261
-279
-8% -$43.4K 0.02% 270
2025
Q3
$474K Buy
3,540
+500
+16% +$52.9K 0.02% 271
2025
Q2
$296K Hold
3,040
0.01% 299
2025
Q1
$221K Buy
+3,040
New +$239K 0.01% 325
2024
Q4
Sell
-2,800
Closed -$229K 333
2024
Q3
$229K Hold
2,800
0.01% 311
2024
Q2
$298K Hold
2,800
0.01% 283
2024
Q1
$272K Hold
2,800
0.01% 288
2023
Q4
$219K Buy
+2,800
New +$191K 0.01% 294
2022
Q1
Sell
-2,800
Closed -$201K 299
2021
Q4
$201K Buy
+2,800
New +$176K 0.01% 297

Other funds holding LRCX

Chesley Taft & Associates's LRCX Position: Q2 2026 in Review

Chesley Taft & Associates increased its Lam Research (LRCX) stake by 1.7% in Q2 2026, buying an estimated $16.1K and bringing the position to 3,106 shares worth $1.35M. The position accounts for 0.05% of the portfolio, ranked #194.

Chesley Taft & Associates first reported a position in LRCX in Q4 2021 and has held it in 11 quarters since. 988 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Chesley Taft & Associates held 3,106 shares of Lam Research worth $1.35M as of Q2 2026.
  • Chesley Taft & Associates bought 53 Lam Research shares in Q2 2026, an estimated $16.1K.
  • Lam Research made up 0.05% of Chesley Taft & Associates's portfolio in Q2 2026, its #194 holding.
  • Chesley Taft & Associates first reported a position in Lam Research in Q4 2021 and has held it in 11 quarters since.
  • 988 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.